IRIS
INCERTI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.420
AS - Asia 5.105
EU - Europa 4.217
SA - Sud America 747
AF - Africa 344
OC - Oceania 2
Totale 15.835
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.266
SG - Singapore 1.745
CN - Cina 1.497
VN - Vietnam 921
IT - Italia 907
IE - Irlanda 643
FI - Finlandia 609
BR - Brasile 594
SE - Svezia 570
DE - Germania 425
HK - Hong Kong 384
UA - Ucraina 310
ZA - Sudafrica 240
FR - Francia 194
NL - Olanda 136
TR - Turchia 117
GB - Regno Unito 112
IN - India 94
CA - Canada 93
RU - Federazione Russa 76
AR - Argentina 74
AT - Austria 51
BD - Bangladesh 43
JP - Giappone 43
BE - Belgio 39
CI - Costa d'Avorio 39
MX - Messico 38
ID - Indonesia 34
IQ - Iraq 34
PH - Filippine 32
KR - Corea 31
ES - Italia 25
CZ - Repubblica Ceca 22
EC - Ecuador 22
TH - Thailandia 22
GR - Grecia 21
VE - Venezuela 20
MA - Marocco 17
HU - Ungheria 15
PK - Pakistan 15
EG - Egitto 14
LT - Lituania 14
PL - Polonia 13
SA - Arabia Saudita 12
UZ - Uzbekistan 11
CO - Colombia 10
KE - Kenya 10
TN - Tunisia 10
JO - Giordania 9
CL - Cile 7
AL - Albania 6
IL - Israele 6
LB - Libano 6
PY - Paraguay 6
BO - Bolivia 5
ET - Etiopia 5
IR - Iran 5
JM - Giamaica 5
NP - Nepal 5
PE - Perù 5
SN - Senegal 5
TW - Taiwan 5
AZ - Azerbaigian 4
CH - Svizzera 4
KZ - Kazakistan 4
OM - Oman 4
RO - Romania 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
HN - Honduras 3
KG - Kirghizistan 3
MY - Malesia 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
SV - El Salvador 3
AM - Armenia 2
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
HR - Croazia 2
KH - Cambogia 2
LK - Sri Lanka 2
NG - Nigeria 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AD - Andorra 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
KY - Cayman, isole 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 15.829
Salva come PNG Salva come JPEG
Città #
Singapore 868
Dublin 642
Ashburn 603
Chandler 551
San Jose 429
Beijing 427
Santa Clara 388
Hong Kong 349
Jacksonville 347
Parma 320
Dallas 285
Ho Chi Minh City 266
Ann Arbor 251
Johannesburg 228
Hanoi 217
Boardman 190
Dearborn 185
Nanjing 155
Los Angeles 123
Shanghai 113
Lauterbourg 111
New York 109
Princeton 108
Izmir 89
Munich 87
Wilmington 83
San Mateo 79
Hefei 70
Bremen 66
São Paulo 61
Toronto 58
Helsinki 55
Shenyang 50
Vienna 49
Chicago 48
Kunming 44
Buffalo 41
Abidjan 39
Grafing 39
Haiphong 37
Moscow 37
Hebei 36
Jinan 36
Nanchang 36
Da Nang 35
Bologna 34
Guangzhou 34
Tokyo 34
Columbus 33
Council Bluffs 33
Brussels 32
Des Moines 29
Tianjin 29
Frankfurt am Main 27
Rome 27
Milan 26
Turku 26
Seattle 24
Houston 23
Modena 22
Rio de Janeiro 22
Woodbridge 22
Jiaxing 21
Pune 20
The Dalles 20
Changsha 19
Jakarta 18
London 17
Chennai 16
Montreal 16
Orem 16
Seoul 16
Belo Horizonte 15
Brasília 15
Poplar 15
Brooklyn 14
Can Tho 14
Denver 14
Fremont 14
Mexico City 14
San Francisco 14
Biên Hòa 13
Brescia 13
Hangzhou 13
Ninh Bình 13
Nuremberg 13
Athens 12
Brno 12
Hải Dương 12
Norwalk 12
Zhengzhou 12
Ankara 11
Atlanta 11
Bắc Ninh 11
Curitiba 11
Baghdad 10
Bangkok 10
Boston 10
Düsseldorf 10
Phoenix 10
Totale 9.444
Salva come PNG Salva come JPEG
Nome #
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 273
Hydroxyphenyl thiosemicarbazones as inhibitors of mushroom tyrosinase and antibrowning agents. 268
A potentiometric and spectrofluorimetric approach to unravel inhibitory effects of semi- and thiosemicarbazones on mushroom tyrosinase activity 242
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 239
Effetto di derivati dell'urea sulla radicazione avventizia in vitro di microtalee micropropagate di corbezzolo 222
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 214
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 202
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 201
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 200
A new efficient route to 7-aryl-6-fluoro-8-nitroquinolones as potent antibacterial agents 198
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 197
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction 196
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses 196
Adventitious rooting adjuvant activity of 1,3-di(benzo[d]oxazol-5-yl) urea and 1,3-di(benzo[d]oxazol-6-yl)urea: new insights and perspectives 191
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 191
Effect of Cl-Substitution on Rooting- or Cytokinin-like Activity of Diphenylurea Derivatives 190
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages 186
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 181
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 176
4-Chloro-N-(4-chlorophenylsulfonyl)-N-(3-oxo-2,3-dihydro-1,2-benzisothiazol-2-yl)benzenesulfonamide 174
A one-pot PPh3-promoted synthesis of new functionalized heterocycles derived from 2-aminobenzo[d]isothiazol-3-one 172
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice 172
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 171
inibitori eph-ephrin biodisponibili oralmente 170
2-Benzo[d]isothiazolylimino-5-arylidene-4-thiazolidinones: Synthesis and antimicrobial activity 168
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors 166
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 164
2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: synthesis and structure-activity relationship. 163
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 161
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 161
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 160
A ONE-POT ENTRY TO A NOVEL 3-H-BENZO[D]PYRAZOLO[1,5-B]ISOTHIAZOLE RING SYSTEM. 159
4-Methyl-N-(3-oxo-2,3-dihydro-1,2-benzisothiazol-2-yl)benzenesulfonamide 159
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 156
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 155
Amidinobenzisothiazole derivatives with antidegenerative activity on cartilage 153
2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction 153
Aminoderivatives of benzothiazole/benzisothiazole heterocycles as intermediates in the synthesis of novel therapeutic agents 150
Evaluation of the anti-tumor activity of small molecules targeting eph/ephrins in apcmin j mice 150
Structure activity relationship of new EphA2 ligands 149
2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction. 148
Design and structure-activity relationships of amino acid derivatives of lithocholic acid as novel EphA2 receptor antagonists. 148
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 148
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 146
New MDR1 inhibitors for overcoming multidrug resistance 146
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists 145
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 144
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 144
2-BENZO[d]ISOTHIAZOLYLIMINO-5-ARYLIDENE-4-THIAZOLIDINONES: SYNTHESIS AND ANTIMICROBIAL ACTIVITY 144
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 143
Combining pharmacology, target hopping and computational medicinal chemistry to discover novel scaffold targeting EPH-ephrin interaction. 142
Synthesis and NMR spectral assignments of novel 1,4-benzothiazepine-5-one derivatives 139
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 138
Computer-Aided Design of Novel Antagonists of the EphA2 Receptor 135
4-thiazolidinone derivatives as MMP inhibitors in tissue damage: Synthesis, biological evaluation and docking studies 135
A one-pot PPh3-promoted synthesis of new functionalized heterocycles derived from 2-aminobenzo[d]isothiazol-3-one 134
Diheteroarylurea derivatives as adventitious rooting adjuvants in mung bean shoots and M26 apple rootstock. 133
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists 133
Structure-activity relationships of N-phenyl-N’-benzothiazol-6-ylurea synthetic derivatives: cytokinin-like activity and adventitious rooting enhancement 131
Effects of a dietary intervention with Mediterranean vs lacto-ovo vegetarian diets on HDL function: results from the CARDIVEG study 130
Are we using the right pharmacological tools to target EphA4? 127
QSAR analysis of 4-thiazolidinone derivatives with antimicrobial activity. 123
Lithocholic acid competitively inhibitis EphA2-ephrinA1 binding: pharmacological and structural considerations. 123
Attività antiproliferativa di N-(1,2-benzisothiaziol-3-il)benzaamidine su cellule di carcinoma colon-rettale umano 123
Target-hopping: a useful approach to identify novel Eph receptor antagonists 122
Complete 1H and 13C NMR spectral assignment of benzo[d]isothiazole derivatives and of an isoindole isoster 121
Lithocholic acid competitively inhibits EphA2-ephrinA1 binding: pharmacological and structural considerations. 121
Synthesis and antimicrobial properties of 2-(benzylidene -amino)-benzo[d]isothiazol-3-ones 120
Weakly cytokinin-active diphenylurea derivatives influence adventitious rooting in M26 Malus pumila microcuttings 120
Synthesis and antiproliferative activity of novel benzo[d]isothiazole compounds bearing a 2,4-dinitrophenyl group. 119
Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as potential biologically active agents 119
Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor. 118
Synthesis and antimicrobial properties of benzothiazole benzenesulfonamides 116
Nucleoside Derivatives of 2,6-Diaminopurine Antivirals: Base-Modified Nucleosides with Broad-Spectrum Antimicrobial Properties 115
Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia 114
Anti-HIV evaluation of benzo[d]isothiazole hydrazones. 114
Synthesis and pharmacological properties of benzisothiazole/benzimidazole derivatives with acidic groups 114
On the Use of 2,5-Dimethyl-Pyrrol-1-yl-Benzoic Acid Derivatives as EPH-Ephrin Antagonists. 112
Antidegenerative activity of heteroarylimino-4-thiazolidinones on human chondrocyte cultures stimulated by IL-1ß 111
Synthesis of benzisoxazole and benzisothiazole derivatives with potential antitumor activity 111
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. 111
Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds 110
Heterocycles [h]-fused to 4-oxoquinoline-3-carboxylic acid. Part XI: Synthesis and antibacterial activity of 4-fluoro-6-oxoimidazo[4,5-h]quinoline-7-carboxylic acids 110
Thiazolyl and isothiazolyl azomethine derivatives with antiinflammatory and antioxidant activities. Synthesis, biological evaluation and structure activity relationships study 109
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 108
Benzisothiazolyliminothiazolidin-4-ones with chondroprotective properties: searching for potent and selective inhibitors of MMP-13. 108
Synthesis and biological evaluation of benzo[d]isothiazole, benzothiazole and thiazole Schiff bases 107
Investigation of the reaction between 3-benzisothiazolones, an isoindole isoster and activated acetylenes: synthesis of novel heterocyclic backbones for building bioactive molecules 105
Lipophilicity estimation of new benzisothiazolone derivatives with anti HIV-1 activity for a rational study of structure-activity relationship 105
Stereospecific effects of benzo(d)isothiazolyloxypropanolamine derivatives at beta-adrenoceptors: synthesis, chiral resolution, and biological activity in vitro 105
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents 101
A Microwave‐Assisted One‐Pot Three‐Step Metal‐Free [4+2] Annulation for the Sustainable Synthesis of Highly Substituted 1,2,4‐Triazines 101
Synthesis and evaluation as antimicrobial agents of novel heteroaryl sulfonamides 98
Synthesis and biological activity of hydrazones of benzo[d]isothiazole hydrazides 98
Synthesis and effect of new N-(1,2-benzo[d]isothiazol-3-yl) benzamidines on IL-1- induced alteration in cartilage metabolism 98
Synthesis of novel 5-arylidene-thiazol-4-ones 2-heteroarylamino substituted as potential antimicrobials 97
Synthesis and Antiproliferative Activity of Benzo[d]isothiazole Hydrazones. 96
Molecular modeling of binding between amidinobenzisothiazoles, with antidegenerative activity on cartilage, and matrix metalloproteinase-3 96
Synthesis and Anticancer Activity of new amidinobenzisothiazoles 91
In vitro and in vivo efficacy of an orally bioavailable antagonist of Eph-ephrin system in tumor angiogenesis and growth 89
Totale 14.561
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 44 100 31
2021/2022674 24 15 20 70 24 55 70 87 37 55 25 192
2022/20232.326 245 261 126 169 217 240 44 145 763 20 62 34
2023/2024858 56 64 40 23 60 191 95 65 20 36 68 140
2024/20252.731 92 166 189 150 305 298 138 127 295 235 241 495
2025/20265.824 545 576 683 629 836 342 642 254 966 351 0 0
Totale 16.013